News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,449 Results
Type
Article (41035)
Company Profile (265)
Press Release (683138)
Multimedia
Podcasts (82)
Webinars (18)
Section
Business (204712)
Career Advice (2026)
Deals (35540)
Drug Delivery (118)
Drug Development (81412)
Employer Resources (173)
FDA (16446)
Job Trends (14955)
News (346513)
Policy (32743)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2575)
Accelerated approval (38)
Adcomms (25)
Allergies (155)
Alliances (49575)
ALS (182)
Alzheimer's disease (1698)
Antibody-drug conjugate (ADC) (339)
Approvals (16729)
Artificial intelligence (556)
Autoimmune disease (192)
Automation (46)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (195)
Biotechnology (174)
Bladder cancer (169)
Brain cancer (60)
Breast cancer (665)
Cancer (5076)
Cardiovascular disease (422)
Career advice (1714)
Career pathing (38)
CAR-T (289)
CDC (50)
Celiac Disease (2)
Cell therapy (773)
Cervical cancer (40)
Clinical research (69921)
Collaboration (1802)
Company closure (4)
Compensation (1222)
Complete response letters (66)
COVID-19 (2721)
CRISPR (98)
C-suite (920)
Cystic fibrosis (145)
Data (6649)
Decentralized trials (2)
Denatured (25)
Depression (146)
Diabetes (527)
Diagnostics (6778)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (269)
Drug pricing (189)
Drug shortages (28)
Duchenne muscular dystrophy (260)
Earnings (90727)
Editorial (59)
Employer branding (21)
Employer resources (152)
Events (117967)
Executive appointments (1007)
FDA (19712)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (25)
Funding (1540)
Gene editing (209)
Generative AI (45)
Gene therapy (635)
GLP-1 (991)
Government (4682)
Grass and pollen (6)
Guidances (387)
Healthcare (18902)
HIV (69)
Huntington's disease (51)
IgA nephropathy (87)
Immunology and inflammation (259)
Immuno-oncology (70)
Indications (142)
Infectious disease (3017)
Inflammatory bowel disease (197)
Inflation Reduction Act (14)
Influenza (124)
Intellectual property (264)
Interviews (316)
IPO (16648)
IRA (50)
Job creations (3644)
Job search strategy (1429)
JPM (58)
Kidney cancer (18)
Labor market (90)
Layoffs (550)
Leadership (33)
Legal (7951)
Liver cancer (94)
Longevity (23)
Lung cancer (676)
Lymphoma (391)
Machine learning (47)
Management (59)
Manufacturing (867)
MASH (172)
Medical device (13817)
Medtech (13886)
Mergers & acquisitions (20012)
Metabolic disorders (1343)
mRNA (167)
Multiple sclerosis (171)
NASH (16)
Neurodegenerative disease (347)
Neuropsychiatric disorders (91)
Neuroscience (3016)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4522)
Now hiring (71)
Obesity (631)
Opinion (270)
Ovarian cancer (173)
Pain (216)
Pancreatic cancer (244)
Parkinson's disease (307)
Partnered (33)
Patents (531)
Patient recruitment (546)
Peanut (60)
People (59083)
Pharmaceutical (60)
Pharmacy benefit managers (30)
Phase 1 (21790)
Phase 2 (30774)
Phase 3 (22934)
Pipeline (6297)
Policy (299)
Postmarket research (2564)
Preclinical (9237)
Press Release (64)
Prostate cancer (261)
Psychedelics (49)
Radiopharmaceuticals (292)
Rare diseases (933)
Real estate (5957)
Recruiting (70)
Regulatory (24752)
Reports (53)
Research institute (2399)
Resumes & cover letters (353)
Rett syndrome (31)
RNA editing (16)
RSV (81)
Schizophrenia (152)
Series A (257)
Series B (193)
Service/supplier (11)
Sickle cell disease (101)
Special edition (22)
Spinal muscular atrophy (160)
Sponsored (42)
Startups (3619)
State (2)
Stomach cancer (18)
Supply chain (113)
Tariffs (84)
The Weekly (55)
Vaccines (1027)
Venture capital (91)
Weight loss (399)
Women's health (103)
Worklife (19)
Date
Today (4)
Last 7 days (609)
Last 30 days (2861)
Last 365 days (29879)
2026 (6176)
2025 (30171)
2024 (35213)
2023 (40075)
2022 (51180)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (86)
Alaska (7)
Arizona (320)
Arkansas (13)
Asia (39332)
Australia (6435)
California (11871)
Canada (3418)
China (1151)
Colorado (499)
Connecticut (510)
Delaware (351)
Europe (84929)
Florida (1793)
Georgia (376)
Hawaii (3)
Idaho (61)
Illinois (915)
India (74)
Indiana (545)
Iowa (22)
Japan (459)
Kansas (127)
Kentucky (43)
Louisiana (34)
Maine (73)
Maryland (1447)
Massachusetts (8513)
Michigan (337)
Minnesota (649)
Mississippi (6)
Missouri (134)
Montana (33)
Nebraska (29)
Nevada (131)
New Hampshire (81)
New Jersey (3161)
New Mexico (28)
New York (3123)
North Carolina (1516)
North Dakota (8)
Northern California (5846)
Ohio (352)
Oklahoma (21)
Oregon (41)
Pennsylvania (2392)
Puerto Rico (24)
Rhode Island (50)
South America (1110)
South Carolina (71)
South Dakota (1)
Southern California (4645)
Tennessee (192)
Texas (1837)
United States (42059)
Utah (357)
Vermont (1)
Virginia (280)
Washington D.C. (80)
Washington State (953)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
724,449 Results for "seaspine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Orthofix Medical Inc. Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results
The merger of equals between Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) became effective as of January 5, 2023.
January 9, 2023
·
13 min read
Deals
Orthofix Medical Reports Orthofix and SeaSpine Fourth Quarter and Full-Year 2022 Results
The merger of Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) became effective as of January 5, 2023.
March 6, 2023
·
25 min read
Press Releases
Otsuka Pharmaceutical Canada Inc. and Lundbeck Canada Inc. secure public reimbursement of ABILIFY ASIMTUFII®
March 4, 2026
·
6 min read
Press Releases
Allosteric Bioscience, Inc. Targets Extending Longevity
March 5, 2026
·
1 min read
Press Releases
Progyny, Inc. Executives to Participate in Upcoming Investor Conferences
March 9, 2026
·
2 min read
Press Releases
Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.
March 10, 2026
·
5 min read
Press Releases
American Aires Inc. Files Legal Proceedings Against Former Executive
March 13, 2026
·
6 min read
Press Releases
Emboline, Inc. Secures $20 Million in Growth Capital from Trinity Capital Inc. to Support Commercialization of the Emboliner® Embolic Protection System to Minimize Stroke Risk From TAVR
March 11, 2026
·
3 min read
Press Releases
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
March 13, 2026
·
8 min read
Press Releases
BioSyent Announces Closing of the Acquisition of Oral Science Inc.
March 2, 2026
·
3 min read
1 of 72,445
Next
